Publications
2017
Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.
Conte C,
Roscini L,
Sardella R,
Mariucci G,
Scorzoni S,
Beccari T,
Corte L.
Neurochem Res. 2017 Feb;42(2):493-500. doi: 10.1007/s11064-016-2095-6. Epub 2017 Jan 21.
2017
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities.
Radic-Sarikas B,
Tsafou KP,
Emdal KB,
Papamarkou T,
Huber KV,
Mutz C,
Toretsky JA,
Bennett KL,
Olsen JV,
Brunak S,
Kovar H,
Superti-Furga G.
Mol Cancer Ther. 2017 Jan;16(1):88-101. doi: 10.1158/1535-7163.MCT-16-0235. Epub 2016 Nov 15.
2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
Pietarinen PO,
Eide CA,
Ayuda-Durán P,
Potdar S,
Kuusanmäki H,
Andersson EI,
Mpindi JP,
Pemovska T,
Kontro M,
Heckman CA,
Kallioniemi O,
Wennerberg K,
Hjorth-Hansen H,
Druker BJ,
Enserink JM,
Tyner JW,
Mustjoki S,
Porkka K.
Oncotarget. 2017 Apr 4;8(14):22606-22615. doi: 10.18632/oncotarget.15146.
2017
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.
Valent P,
Herndlhofer S,
Schneeweiß M,
Boidol B,
Ringler A,
Kubicek S,
Gleixner KV,
Hoermann G,
Hadzijusufovic E,
Müllauer L,
Sperr WR,
Superti-Furga G,
Mannhalter C.
Oncotarget. 2017 Apr 4;8(14):23061-23072. doi: 10.18632/oncotarget.15481.
2017
Global survey of the immunomodulatory potential of common drugs.
Vladimer GI,
Snijder B,
Krall N,
Bigenzahn JW,
Huber KVM,
Lardeau CH,
Sanjiv K,
Ringler A,
Berglund UW,
Sabler M,
de la Fuente OL,
Knöbl P,
Kubicek S,
Helleday T,
Jäger U,
Superti-Furga G.
Nat Chem Biol. 2017 Jun;13(6):681-690. doi: 10.1038/nchembio.2360. Epub 2017 Apr 24.
2017
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter.
Radic-Sarikas B,
Halasz M,
Huber KVM,
Winter GE,
Tsafou KP,
Papamarkou T,
Brunak S,
Kolch W,
Superti-Furga G.
Sci Rep. 2017 Jun 8;7(1):3091. doi: 10.1038/s41598-017-03129-6.
2017
Natural RNA Polymerase Aptamers Regulate Transcription in E.
Sedlyarova N,
Rescheneder P,
Magán A,
Popitsch N,
Rziha N,
Bilusic I,
Epshtein V,
Zimmermann B,
Lybecker M,
Sedlyarov V,
Schroeder R,
Nudler E.
coli. Mol Cell. 2017 Jul 6;67(1):30-43.e6. doi: 10.1016/j.molcel.2017.05.025. Epub 2017 Jun 22.
2017
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.
Hadzijusufovic E,
Albrecht-Schgoer K,
Huber K,
Hoermann G,
Grebien F,
Eisenwort G,
Schgoer W,
Herndlhofer S,
Kaun C,
Theurl M,
Sperr WR,
Rix U,
Sadovnik I,
Jilma B,
Schernthaner GH,
Wojta J,
Wolf D,
Superti-Furga G,
Kirchmair R,
Valent P.
Leukemia. 2017 Nov;31(11):2388-2397. doi: 10.1038/leu.2017.245. Epub 2017 Jul 31.
2017
LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent late endosomal positioning.
Filipek PA,
de Araujo MEG,
Vogel GF,
De Smet CH,
Eberharter D,
Rebsamen M,
Rudashevskaya EL,
Kremser L,
Yordanov T,
Tschaikner P,
Fürnrohr BG,
Lechner S,
Dunzendorfer-Matt T,
Scheffzek K,
Bennett KL,
Superti-Furga G,
Lindner HH,
Stasyk T,
Huber LA.
J Cell Biol. 2017 Oct 9. pii: jcb.201703061. doi: 10.1083/jcb.201703061. [Epub ahead of print]
2016
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity, Cell 2017 Jan 12 (epub ahead of print 2016 Dec 1);168(1), 86-100.
Li J,
Casteels T,
Frogne T,
Ingvorsen C,
Honoré C,
Courtney M,
Huber KVM,
Schmitner N,
Kimmel RA,
Romanov RA,
Sturtzel C,
Lardeau CH,
Klughammer J,
Farlik M,
Sdelci S,
Vieira A,
Avolio F,
Briand F,
Baburin I,
Májek P,
Pauler FM,
Penz T,
Stukalov A,
Gridling M,
Parapatics K,
Barbieux C,
Berishvili E,
Spittler A,
Colinge J,
Bennett KL,
Hering S,
Sulpice T,
Bock C,
Distel M,
Harkany T,
Meyer D,
Superti-Furga G,
Collombat P,
Hecksher-Sørensen J,
and Kubicek S.
doi:10.1016/j.cell.2016.11.010. Abstract: http://www.cell.com/cell/abstract/S0092-8674(16)31531-8
